Immunotherapy and targeted therapies for colorectal liver metastasis
Author:
Manne Ashish,Noonan Anne
Reference104 articles.
1. Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer;André;New England Journal of Medicine,2020
2. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials;Arnold;Annals of Oncology,2017
3. Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: overall and KRAS-Specific Results of the NCIC CTG and AGITG CO.17 Trial;Au;Journal of Clinical Oncology,2009
4. Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer;Balint;Cancer Immunology, Immunotherapy,,2015
5. A Randomized Trial of Ex vivo CD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: tumor-Specific Immune Responses Are Associated with Improved Survival;Barth;Clinical Cancer Research,2010